 The ASAC trial is a Scandinavian, multi-center, double-blinded, randomized, placebo-controlled study to determine whether adjuvant treatment with low-dose acetylsalicylic acid ASA can improve disease free survival in patients treated with resection for colorectal cancer liver metastases CRCLM. 